Cite
HARVARD Citation
Gibiansky, E. et al. (2021). Ocrelizumab in relapsing and primary progressive multiple sclerosis: Pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO. British journal of clinical pharmacology. 87 (6), pp. 2511-2520. [Online].